Ambros Therapeutics, Inc.
PrivateLast Round
Series A
Dec 16, 2025
Total Funding Raised
$125M
Momentum Score
75 /100
Company Overview
Ambros Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of innovative and transformative medicines for diseases with a high unmet medical need, with its lead program targeting complex regional pain syndrome type 1 (CRPS-1).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ambros Therapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
Ambros Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 16, 2025 |
Key People
Founding team and executive leadership
Ambros Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Enavate Sciences | Series A |
| Janus Henderson Group | Series A |
| Balyasny Asset Management L.P. | Series A |
| RA Capital Management | Series A |
| Adage Capital Partners, L.P. | Series A |
| Transhuman Capital | Series A |
| Arkin Bio Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2026
Grew 45% QoQ, from 20 to 29 employees.
- Apr 17, 2026
Monthly visitors increased 78% MoM.
Ambros Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ambros Therapeutics, Inc.'s valuation, stock price, and market status.
